¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Triple Amino Acid Complex Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
  • orotic acid
    ¿À·ÎÆ®»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
  • phosphoric acid
    Àλê
  • phosphorus acid
    ¾ÆÀλê
  • p-aminobenzoic acid
    ÆÄ¶ó¾Æ¹Ì³ëº¥Á¶»ê
  • p-aminosalicylic acid
    ÆÄ¶ó¾Æ¹Ì³ë»ì¸®½Ç»ê
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • picramic acid
    ÇÇÅ©¶÷»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • uridine diphosphate glucuronic acid
    ÀÌÀλêÀ¯¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    À¯·ÎÄ«´Ñ»ê
  • uronic acid
    À¯·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµð¿Á½ÃÄݸ°»ê
  • volatile acid
    Èֹ߼º»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®¸£»êȸ·Î
  • tricarboxylic acid cycle
    »ïÄ«¸£º¹½Ç»êȸ·Î
  • nucleic acid hybridization
    ÇÙ»êºÎÇÕÈ­
  • uric acid infarct
    ¿ä»ê°æ»ö
  • nucleic acid probe
    ÇÙ»ê´õµëÀÚ
  • uric acid nephropathy
    (¢¡urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • oral fissure
    ±¸¿­
  • oral fissure ³ª rima oris
    ÀÔ¼úÆ´»õ, ±¸¿­ (Ï¢æñ).
  • oral fixation
    ±¸°­±â °íÂø(ͳó·)
  • oral floor
    ±¸°­Àú
  • oral floor
    ±¸°­Àú(Ϣ˷î¼).
  • oral flora
    ±¸°­±ÕÃÑ
  • oral flora
    ±¸°­±ÕÃÑ(Ϣ˷жõ¿).
  • oral florid papillomatosis
    ÀÔ¾È ²É À¯µÎÁ¾Áõ
  • oral focal epithelial hyperplasia
    ±¸°­ ±¹¼Ò»óÇÇÁõ½Ä
  • oral focal infection
    ±¸°­º´¼Ò°¨¿°
  • oral focal infection
    ±¸°­º´¼Ò°¨¿°(Ϣ˷ܻᵠÊïæø).
  • oral gland(s)
    ±¸°­¼±, ±¸°­»ù
  • oral gland(s)
    ±¸°­¼±(Ϣ˷àÍ).
  • oral glucose tolerance test =OGTT
    °æ±¸Æ÷µµ´çºÎÇϽÃÇè.
  • oral habit
    ±¸º®(Ï¢Ûþ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • glycocholic acid
    ±Û¶óÀÌÄÚÄÝ»ê(ß«)
  • glycolic acid cycle
    ±Û¶óÀÌÄÝ»ê(ß«) ȸ·Î(üÞÖØ)
  • glyconic acid
    ´ç»ê(ÓØß«)
  • glycuronic acid
    ±Û¶óÀÌÅ¥·Ð»ê(ß«)
  • glycyrrhizinic acid
    ±Û¶óÀ̽ø®Áø»ê(ß«)
  • glyoxylic acid reaction
    ±Û¶óÀÌ¿Á½Ç»ê(ß«) ¹ÝÀÀ(Úãëë)
  • guanidino acetic acid
    ±¸¾Æ´Ïµð¿À ¾Æ¼¼Æ®»ê(ß«)
  • guanylic acid
    ±¸¾Æ´Ò»ê(ß«)
  • heterofermentative lactic acid bacteria
    ÀÌÁ¾¹ßÈ¿(ì¶ðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • hexuronic acid
    Çí½´·Ð »ê(ß«)
  • hippuric acid
    ¸¶´¢»ê(Ø©Òãß«)
  • homoamino acid
    È£¸ð¾Æ¹Ì³ë»ê(ß«)
  • homofermentative lactic acid bacteria
    µ¿Á¾¹ßÈ¿(ÔÒðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • homogentisic acid
    È£¸ðÁ¨Æ¾»ê(ß«)
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
Fd the amino-terminal portion of the heavy chain of an immunoglobulin molecule; ferredoxin
NAAP N-acetyl-4-amino-phenazone
Nt amino terminal
OKT ornithine ketoacid amino-transferase
TAGH triiodothyronine, amino acids, glucagon, and heparin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
OAC Oral anticoagulant
OAT Oral anticoagulant therapy
OA Oral anticoagulants
OC Oral candidiasis
OCG Oral cholecystography
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • mycolic acid
    ¹ÌÄÝ»ê.
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p-¾Æ¹Ì³ë ¾È½ÄÇâ»ê
  • nalidixic acid
    ³¯¸®µñ½º»ê
    C
  • naphthalenesulfonic acid
    ³ªÇÁÅ»·» ¼úÆù»ê
    ³ªÇÁÅ»·»À» ¼úÆùÈ­½ÃŰ¸é »ý±â´Â È­ÇÕ¹°. 1-³ªÇÁÅ»·» ¼úÆù»ê°ú 2-³ªÇÁÅ»·» ¼úÆù»êÀÇ µÎ À̼ºÁúü°¡ ÀÖ´Ù. ÀüÀÚ´Â 60 ¡É ÀÌÇÏÀÇ ¹ÝÀÀ ¿Âµµ¿¡¼­ ¾òÀ» ¼ö ÀÖ°í, ÈÄÀÚ´Â 165 ¡É¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ¾ËÄ®¸® À¶ÇØÇÏ¸é ³ªÇÁÅçÀ» ¾ò´Â´Ù. ³ªÇÁÅ»·»À» ¿ø·á·Î ÇÏ´Â ¿°·á´Â ´ëºÎºÐ ³ªÇÁÅ»·» ¼úÆù»êÀ» °ÅÃÄ ÇÕ¼ºµÇ¹Ç·Î ¿°·á °ø¾÷¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. ¸ð³ë ¼úÆù»êÀ» ´Ù½Ã ¼úÆùÈ­Çϸé Á¶°Ç¿¡ µû¶ó ¿©·¯ ¼úÆù»êÀÌ »ý±ä´Ù. ¶Ç ³ªÇÁÅç ¼úÆù»êÀÇ ¾Æ¹Ì³ë À¯µµÃ¼, ³ªÇÁÅç ¼úÆù»ê µîÀÌ ¿°·á Áß°£Ã¼·Î¼­ ¸¹ÀÌ »ý¼ºµÈ´Ù.
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nissl's acid
    ´Ï½½»ê
    »ê¼º¾× ¶Ç´Â ¾Ï¸ð´Ï¾Æ¿¡ ³ì´Â´Ù.
  • nitrobenzoic acid
    ´ÏÆ®·Î ¾È½ÄÇâ »ê
    NO2C6H4COOH. ´ÏÆ®·Î Åç·ç¿ÃÀÌ »êÈ­µÇ¾î »ý±â´Â È­ÇÕ¹°.
  • nitroferrocyanic acid
    ´ÏÆ®·Î Æä·Î½Ã¾È»ê
    H2[Fe
  • octanoic acid
    ¿ÁÅ×Àλê
  • oleic acid
    ¿Ã·¹»ê
    µ¿½Ä¹°¿¡ ³Î¸® Á¸ÀçÇÏ´Â Áö¹æ»ê. È­ÇÐ½Ä C8H4O, ³ì´ÂÁ¡ 12 ¡É, ²ú´ÂÁ¡ 360 ¡ÉÀÌ´Ù. ÀÌÁß °áÇÕÀ» 1°³ °¡Áö´Â ºÒÆ÷È­ Áö¹æ»êÀÌ´Ù. ¹°¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª, ¿¡Åº¿Ã, ¿¡Å׸£, Ŭ·Î·ÎÆ÷¸§ µî¿¡´Â ³ì´Â´Ù. ¹é±ÝÈæ, ´ÏÄÌ µîÀ» Ã˸ŷΠÇÏ¿© ¼ö¼Ò·Î ȯ¿ø½ÃŰ¸é Æ÷È­ÀÎ ½ºÅ׾Ƹ£»êÀÌ µÈ´Ù. ¼ø¼öÇÑ °ÍÀº ¹«»ö, ¹«ÃëÀÎ À¯»ó ¾×üÀ̳ª, °ø±â ¼Ó¿¡ ¹æÄ¡ÇØ µÎ¸é »êÈ­µÇ¾î Ȳ»ö ¶Ç´Â °¥»öÀ¸·Î Âø»öµÇ°í ½â´Â ³¿»õ°¡ ³­´Ù. µ¿¹°¿¡¼­´Â ±Û¸®¼¼¸°°ú ¿¡½ºÅ׸£¸¦ Çü¼ºÇÏ¿© ÇÇÇÏ Áö¹æÀ̳ª °£¿¡ ÀúÀåµÈ´Ù. °ø¾÷ÀûÀ¸·Î ¿ëµµ°¡ ³ÐÀ¸¸ç, ºñ´©ÀÇ ¿ø·á³ª õÀÇ ¹æ¼öÁ¦·Î¼­ ÀÌ¿ëµÈ´Ù.
  • ophthalmic acid
    ¿ÀÇÁÅ»¹Î»ê
    ¼ÒÀÇ ¼öÁ¤Ã¼ Áß¿¡ Á¸ÀçÇÏ´Â Æ®¶óÀÌ ÆéŸÀ̵å.
  • organic acid
    À¯±â»ê
    1. ¿øÀÚ´ÜÀÌ Åº¼Ò À¯µµÃ¼ÀÎ »ê. źȭ¼ö¼Ò±â°¡ COOH³ª SO3H¿Í °áÇÕÇϰí ÀÖ´Â È­ÇÕ¹°. 2. »ê¼ºÀ» ¶ì´Â À¯±âÈ­ÇÕ¹°ÀÇ ÃÑĪ. ¹«±â»ê°ú ´ëÀÀÇÏ´Â ¸»·Î¼­ ¾Æ¼¼Æ®»ê, ºÎƼ¸£»ê, ÆÈ¹ÌÆ®»ê, ¿Á»ì»ê, Ÿ¸£Å¸¸£»ê µîÀÌ ÀÖ´Ù. ±× ´ëºÎºÐÀº Ä«¸£º¹½Ã»êÀ̹ǷΠÁ¼Àº ¶æÀ¸·Î´Â Ä«¸£º¹½Ã»êÀ» °¡¸®Å²´Ù. ±×·¯³ª ¾Æ½ºÄÚ¸£ºê»êÀ̳ª ¿ä»ê
  • oxalacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantotheic acid
    ÆÇÅäÅÙ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
synaptinemal complex A submicroscopic structure interposed between the homologous chromosome pairs during synapsis.
Synonym: synaptonemal complex.
(05 Mar 2000)
synaptonemal complex <cell biology> Structure, identified by electron microscopy, lying between chromosomes during synapsis, consists of two lateral plates closely apposed to the chromosomes and connected to a central plate by filaments. It appears to act as a scaffold and is essential for crossing over.
(18 Nov 1997)
Diana complex Ideas leading to the adoption of masculine traits and behaviour in a female.
Origin: Diana, L. Myth. Char.
(05 Mar 2000)
diphasic complex A complex consisting of both positive and negative deflections.
(05 Mar 2000)
immune complex <immunology> Multimolecular antibody antigen complexes that may be soluble or insoluble depending upon their size and whether or not complement is present.
Immune complexes can be filtered from plasma in the kidney and the deposition of the complexes gives rise to glomerulonephritis probably because of the trapping of neutrophils via their Fc receptors.
(18 Nov 1997)
immune complex disease An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
immune complex diseases Diseases characterised by the presence of immune complexes in body fluids. Hypersensitivity of the Arthus type and serum sickness are examples.
(18 Nov 1997)
immune complex disorder An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
immune complex glomerulonephritis Immune complexes are deposited in the renal glomerulus where they bind complement and initiate an inflammatory process attracting neutrophils and macrophages resulting in an alteration of the basement layer of the kidney. The disease state can lead to ultimate destruction of the glomerulus and renal failure.
(05 Mar 2000)
immune complex nephritis An immune complex disease resulting from glomerular deposits, as in systemic lupus erythematosus.
(05 Mar 2000)
QRS complex <cardiology> The deflections in an electrocardiographic tracing and represent ventricular activity of the heart.
(13 Nov 1997)
inferiority complex A sense of inadequacy which is expressed in extreme shyness, diffidence, or timidity, or as a compensatory reaction in exhibitionism or aggressiveness.
(05 Mar 2000)
initiation complex Complex between mRNA, 30S ribosomal subunit and formyl methionyl tRNA that requires GTP and initiation factors to function.
(18 Nov 1997)
iron-dextran complex <chemical> Iron dextran. A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a haematinic. (goodman and gilman's the pharmacological basis of therapeutics, 8th ed, p1292)
Pharmacological action: haematinics.
Chemical name: Iron dextran
(12 Dec 1998)
iron succinyl milk protein complex <chemical> Soluble iron complex with 5% iron content produced by reacting succinylated milk protein and ferric chloride
Synonym: iron succinyl protein complex, itf 282, itf-282
(05 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á